Product Safety Recalls

Product Recall Tracker

ARIPIPRAZOLE Recall D-1285-2022

Description: Aripiprazole Tablets, USP 20 mg, packaged in a) 1,000-count bottle (NDC 60505-2676-8, UPC 3 60505 26768 2), b) 30-count bottle (NDC 60505-2676-3, UPC 3 60505 26763 7), Rx only, Manufactured by: Apotex, Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326

ARIPIPRAZOLE Recall D-1285-2022 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-1285-2022
Event ID90569
BrandARIPIPRAZOLE
Generic NameARIPIPRAZOLE
ManufacturerARIPIPRAZOLE
Original Package?1
Active SubstanceARIPIPRAZOLE
Drug RouteORAL
DistributionUSA Nationwide
Quantity2010 bottles
Recall ReasonFailed dissolution specifications: OOS for dissolution at the 12-month stability time point.
Drug ClassificationClass II
Drug Code Info20220727
Product NDC60505-2673 60505-3075 60505-2674
Product NUIN0000175430
Drug UPC360505267682 360505267637
Pharma Class (EPC)Atypical Antipsychotic [EPC]
Recall Initiation Date20220707
Report Date20220727
Classification Date20220721
Address2400 N Commerce Pkwy Ste 400
Weston, FL 33326-3253
United States
Recalling FirmApotex Corp.
Initial Notification Letter
Unique Ingredient Identifier82VFR53I78
Drug Application NumberANDA078583
Structured Product Labeling (SPL ID)40ac4f7e-0729-b1f9-3951-e5bc26008e2e
Structured Product Labeling (SPL Set ID)569f1c32-fb6f-c34f-0894-4b1e7b744a8a
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.